2008
DOI: 10.1016/s0083-6729(07)00003-9
|View full text |Cite
|
Sign up to set email alerts
|

The Vitamin K Cycle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
106
0
8

Year Published

2010
2010
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 153 publications
(116 citation statements)
references
References 129 publications
2
106
0
8
Order By: Relevance
“…10% of all adverse drug reactions leading to hospital admission. 4 Warfarin works by inhibiting the C1 subunit of vitamin K epoxide reductase enzyme (encoded by VKORC1 ) and by interfering with cyclic interconversion of vitamin K 5 essential for the activation of vitamin K-dependent clotting factors such as II, VII, IX, and X as well as endogenous anticoagulant factors, protein C, and protein S. 6 Clinically available warfarin is a racemic molecule, which presents as S -warfarin and R -warfarin. 7 S -warfarin, compared with R -warfarin, is approximately fi ve times more active as a VKOR inhibitor and is converted to inactive metabolites by CYP2C9, encoded by CYP2C9 .…”
Section: [ 1 4 8 # 3 C H E S T S E P T E M B E R 2 0 1 5 ]mentioning
confidence: 99%
“…10% of all adverse drug reactions leading to hospital admission. 4 Warfarin works by inhibiting the C1 subunit of vitamin K epoxide reductase enzyme (encoded by VKORC1 ) and by interfering with cyclic interconversion of vitamin K 5 essential for the activation of vitamin K-dependent clotting factors such as II, VII, IX, and X as well as endogenous anticoagulant factors, protein C, and protein S. 6 Clinically available warfarin is a racemic molecule, which presents as S -warfarin and R -warfarin. 7 S -warfarin, compared with R -warfarin, is approximately fi ve times more active as a VKOR inhibitor and is converted to inactive metabolites by CYP2C9, encoded by CYP2C9 .…”
Section: [ 1 4 8 # 3 C H E S T S E P T E M B E R 2 0 1 5 ]mentioning
confidence: 99%
“…Whereas GGCX produces Gla residues in the substrate protein, the co-substrate of GGCX, vitamin K hydroquinone (vit KH2), is oxygenated into vitamin K 2,3-epoxide (vit KϾO) (9) (Fig. 1).…”
mentioning
confidence: 99%
“…However, along with the fact that systemically administered antioxidant effects of green tea reduce the incident of dental caries, vitamin K2 may prove to be an even more potent antioxidant [20][21][22][23][24].…”
Section: A Systemic Approach and The Impact Of Oxidation Controlmentioning
confidence: 99%
“…Hence, it can be construed that there exists a close relationship between both of these exocrine/endocrine glands through the hypothalamus. High levels of vitamin K2 are also located in the brain, heart, and bone [40,41] which definitely is of significance for many disease states, including dental caries, which has been shown to be associated with oxidative stress [6,24].…”
Section: A Summary Of the Features Of Vitamin K2mentioning
confidence: 99%